Several mechanisms of resistance to venetoclax have been reported [88] involving the up-regulation of antiapoptotic molecules Mcl-1 and Bcl-xL, mutations in genes controlling different kinase pathways, transcription factors, epigenetic modifiers, and tumor suppressors. Here, BCL2L1 is linked to neoplasm.